{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:34:37Z","timestamp":1789475677045,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1015-7","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T15:04:47Z","timestamp":1558019087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Linear scleroderma \u201cen coup de sabre\u201d with extensive brain involvement\u2014Clinicopathologic correlations and response to anti-Interleukin-6 therapy"],"prefix":"10.1186","volume":"14","author":[{"given":"Cynthia M.","family":"Magro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Halteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Kister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"issue":"3","key":"1015_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","volume":"53","author":"C Ferreli","year":"2017","unstructured":"Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol. 2017;53(3):306\u201336.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2Pt2","key":"1015_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0190-9622(98)70586-9","volume":"38","author":"Y Soma","year":"1998","unstructured":"Soma Y, Fujimoto M. Frontoparietal scleroderma (en coup de sabre) following Blaschko's lines. J Am Acad Dermatol. 1998;38(2Pt2):366\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"19","key":"1015_CR3","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1212\/01.wnl.0000334474.88923.e3","volume":"71","author":"I Kister","year":"2008","unstructured":"Kister I, Inglese M, Laxer RM, Herbert J. Neurologic manifestations of localized scleroderma: a case report and literature review. Neurology. 2008;71(19):1538\u201345.","journal-title":"Neurology"},{"issue":"2","key":"1015_CR4","first-page":"171","volume":"13","author":"AV Marzano","year":"2003","unstructured":"Marzano AV, Menni S, Parodi A, et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol. 2003;13(2):171\u20136.","journal-title":"Eur J Dermatol"},{"issue":"4","key":"1015_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/ard.50.4.260","volume":"50","author":"J David","year":"1991","unstructured":"David J, Wilson J, Woo P. Scleroderma \u201cen coup de sabre\u201d. Ann Rheum Dis. 1991;50(4):260\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"1015_CR6","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1212\/01.wnl.0000295701.56822.6f","volume":"69","author":"B Echenne","year":"2007","unstructured":"Echenne B, Sebire G. Parry Romberg syndrome and linear scleroderma in coup de sabre mimicking Rasmussen encephalitis. Neurology. 2007;69(24):2274.","journal-title":"Neurology"},{"key":"1015_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jnnp.70.3.382","volume":"70","author":"J Stone","year":"2001","unstructured":"Stone J, Franks AJ, Guthrie JA, Johnson MH. Scleroderma \u201cen coup de sabre\u201d: pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry. 2001;70:382\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1015_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/ard.2010.133587","volume":"70","author":"TC Barnes","year":"2011","unstructured":"Barnes TC, Spiller DG, Anderson ME, Edwards SW, Moots RJ. Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signaling: a novel target for systemic sclerosis? Ann Rheum Dis. 2011;70(2):366\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1015_CR9","first-page":"1207","volume":"19","author":"CA Feghali","year":"1992","unstructured":"Feghali CA, Bost KL, Boulware DW, Levy LS. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol. 1992;19(8):1207\u201311.","journal-title":"J Rheumatol"},{"issue":"5","key":"1015_CR10","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jaad.2008.06.022","volume":"59","author":"CM Magro","year":"2008","unstructured":"Magro CM, Dyrsen ME. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease. J Am Acad Dermatol. 2008;59(5):822\u201333.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1015_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.410270402","volume":"27","author":"AM Emslie-Smith","year":"1990","unstructured":"Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol. 1990;27(4):343\u201356.","journal-title":"Ann Neurol"},{"issue":"7","key":"1015_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","volume":"17","author":"AG Engel","year":"1986","unstructured":"Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol. 1986;17(7):704\u201321.","journal-title":"Hum Pathol"},{"issue":"1","key":"1015_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0046-8177(96)90132-X","volume":"27","author":"AN Crowson","year":"1996","unstructured":"Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol. 1996;27(1):15\u20139.","journal-title":"Hum Pathol"},{"issue":"Suppl 3","key":"1015_CR14","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1186\/ar586","volume":"4","author":"MJ Walport","year":"2002","unstructured":"Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res. 2002;4(Suppl 3):S279\u201393.","journal-title":"Arthritis Res"},{"issue":"6","key":"1015_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1309\/AJCPERI7LC4VNFYK","volume":"136","author":"CM Magro","year":"2011","unstructured":"Magro CM, Poe JC, Lubow M, Susac JO. Susac syndrome an organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies. Am J Clin Pathol. 2011;136(6):903\u201312.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"1015_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","volume":"135","author":"CM Magro","year":"2011","unstructured":"Magro CM, Poe JC, Kim C, et al. Degos disease: a C5b-9\/interferon-alpha-mediated endotheliopathy syndrome. Am J Clin Pathol. 2011;135(4):599\u2013610.","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"1015_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0167-5699(91)90001-A","volume":"12","author":"T Kinoshita","year":"1991","unstructured":"Kinoshita T. Biology of complement: the overture. Immunol Today. 1991;12(9):291\u20135.","journal-title":"Immunol Today"},{"issue":"4760","key":"1015_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.2425429","volume":"233","author":"JD Young","year":"1986","unstructured":"Young JD, Cohn ZA, Podack ER. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological and functional similarities. Science. 1986;233(4760):184\u201390.","journal-title":"Science"},{"issue":"2","key":"1015_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/art.27224","volume":"62","author":"S Assassi","year":"2010","unstructured":"Assassi S, Mayes MD, Arnett FC, et al. Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum. 2010;62(2):589\u201398.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1015_CR20","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/ard.2009.121400","volume":"69","author":"ML Eloranta","year":"2010","unstructured":"Eloranta ML, Frank-Larsson K, Lovgren T, et al. Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis. 2010;69(7):1396\u2013402.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1015_CR21","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.3899\/jrheum.080418","volume":"35","author":"P Airo","year":"2008","unstructured":"Airo P, Ghidini C, Zanotti C, et al. Upregulation of myxovirus-resistance protein a: a possible marker of type I interferon induction in systemic sclerosis. J Rheumatol. 2008;35(11):2192\u2013200.","journal-title":"J Rheumatol"},{"issue":"7","key":"1015_CR22","first-page":"1017","volume":"3","author":"M Kaplan","year":"2002","unstructured":"Kaplan M. Eculizumab (Alexion). Curr Opin Investig Drugs. 2002;3(7):1017\u201323.","journal-title":"Curr Opin Investig Drugs"},{"key":"1015_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1750-1172-8-185","volume":"8","author":"CM Magro","year":"2013","unstructured":"Magro CM, Wang X, Garrett-Bakelman F, Laurence J, Shapiro LS, DeSancho MT. The effects of eculizumab on the pathology of malignant atrophic papulosis. Orphanet J Rare Dis. 2013;8:185.","journal-title":"Orphanet J Rare Dis"},{"key":"1015_CR24","doi-asserted-by":"publisher","first-page":"721608","DOI":"10.1155\/2011\/721608","volume":"2011","author":"TC Barnes","year":"2011","unstructured":"Barnes TC, Anderson ME, Moots RJ. The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol. 2011;2011:721608.","journal-title":"Int J Rheumatol"},{"issue":"8","key":"1015_CR25","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V80.8.2012.2012","volume":"80","author":"F Colotta","year":"1992","unstructured":"Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80(8):2012\u201320.","journal-title":"Blood"},{"issue":"19","key":"1015_CR26","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1128\/MCB.21.19.6615-6625.2001","volume":"21","author":"M Narimatsu","year":"2001","unstructured":"Narimatsu M, Maeda H, Itoh S, et al. Tissue-specific autoregulation of thestat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol Cell Biol. 2001;21(19):6615\u201325.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1015_CR27","first-page":"275","volume":"33","author":"T Matsushita","year":"2006","unstructured":"Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol. 2006;33(2):275\u201384.","journal-title":"J Rheumatol"},{"key":"1015_CR28","doi-asserted-by":"crossref","unstructured":"Fleming JN, Schwartz SM. The pathology of scleroderma vascular disease. Rheum Dis Clin N Am. 2008;34(1):41\u201355.","DOI":"10.1016\/j.rdc.2008.01.001"},{"key":"1015_CR29","doi-asserted-by":"crossref","unstructured":"Patschan S, Nemirovsky K, Henze E, Scholze J, M\u00fcller GA, Patschan D. Tocilizumab increases EPC regeneration in rheumatoid arthritis. Scand J Rheumatol. 2014;43(6):528-30.","DOI":"10.3109\/03009742.2014.926985"},{"issue":"10","key":"1015_CR30","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/ard.2006.066605","volume":"66","author":"J Grisar","year":"2007","unstructured":"Grisar J, Aletaha D, Steiner CW, et al. Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Ann Rheum Dis. 2007;66(10):1284\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1015_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJMoa022287","volume":"348","author":"JM Hill","year":"2003","unstructured":"Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593\u2013600.","journal-title":"N Engl J Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1015-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T23:20:57Z","timestamp":1589498457000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1015-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1015-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]},"assertion":[{"value":"31 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient has consented for her information to be used for this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"110"}}